WO2001018250A3 - Single nucleotide polymorphisms in genes - Google Patents

Single nucleotide polymorphisms in genes Download PDF

Info

Publication number
WO2001018250A3
WO2001018250A3 PCT/US2000/024503 US0024503W WO0118250A3 WO 2001018250 A3 WO2001018250 A3 WO 2001018250A3 US 0024503 W US0024503 W US 0024503W WO 0118250 A3 WO0118250 A3 WO 0118250A3
Authority
WO
WIPO (PCT)
Prior art keywords
gene
single nucleotide
nucleotide polymorphisms
development
nucleic acid
Prior art date
Application number
PCT/US2000/024503
Other languages
French (fr)
Other versions
WO2001018250A2 (en
Inventor
Eric S Lander
Michele Gargill
James S Ireland
Stacey Bolk
George Q Daley
Jeanette J Mccarthy
Original Assignee
Whitehead Biomedical Inst
Millennium Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Whitehead Biomedical Inst, Millennium Pharm Inc filed Critical Whitehead Biomedical Inst
Priority to EP00959964A priority Critical patent/EP1240354A2/en
Priority to AU71194/00A priority patent/AU7119400A/en
Publication of WO2001018250A2 publication Critical patent/WO2001018250A2/en
Publication of WO2001018250A3 publication Critical patent/WO2001018250A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Abstract

The invention provides nucleic acid segments of the human genome, particularly nucleic acid segments from a gene, including polymorphic sites. Allele-specific primers and probes hybridizing to regions flanking or containing these sites are also provided. The nucleic acids, primers and probes are used in applications such as phenotype correlations, forensics, paternity testing, medicine and genetic analysis. A role for the thrombospondin gene(s) in vascular disease is also disclosed. Use of single nucleotide polymorphisms in the thrombospondin gene(s) for diagnosis, prediction of clinical course and treatment response, development of therapeutics and development of cell-culture-based and animal models for research and treatment are disclosed.
PCT/US2000/024503 1999-09-10 2000-09-07 Single nucleotide polymorphisms in genes WO2001018250A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP00959964A EP1240354A2 (en) 1999-09-10 2000-09-07 Single nucleotide polymorphisms in genes
AU71194/00A AU7119400A (en) 1999-09-10 2000-09-07 Single nucleotide polymorphisms in genes

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US15335799P 1999-09-10 1999-09-10
US60/153,357 1999-09-10
US22094700P 2000-07-26 2000-07-26
US60/220,947 2000-07-26
US22572400P 2000-08-16 2000-08-16
US60/225,724 2000-08-16

Publications (2)

Publication Number Publication Date
WO2001018250A2 WO2001018250A2 (en) 2001-03-15
WO2001018250A3 true WO2001018250A3 (en) 2002-07-25

Family

ID=27387432

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/024503 WO2001018250A2 (en) 1999-09-10 2000-09-07 Single nucleotide polymorphisms in genes

Country Status (3)

Country Link
EP (1) EP1240354A2 (en)
AU (1) AU7119400A (en)
WO (1) WO2001018250A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0000995D0 (en) * 2000-01-18 2000-03-08 Zeneca Ltd Methods
US6774209B1 (en) 2000-04-03 2004-08-10 Dyax Corp. Binding peptides for carcinoembryonic antigen (CEA)
EP1403380A1 (en) * 2002-09-27 2004-03-31 Integragen Human obesity susceptibility gene and uses thereof
ATE412778T1 (en) * 2002-05-15 2008-11-15 Integragen Sa HUMAN OBESITY SUSCEPTIBILITY GENES AND THEIR USES
JP4143756B2 (en) 2002-06-21 2008-09-03 財団法人名古屋産業科学研究所 Risk diagnosis method for myocardial infarction
JP5479663B2 (en) * 2002-12-20 2014-04-23 セレラ コーポレーション Genetic polymorphism associated with myocardial infarction, detection method and use thereof
CA2555259A1 (en) * 2004-02-27 2005-09-09 Applera Corporation Genetic polymorphisms associated with stroke, methods of detection and uses thereof
WO2008018789A2 (en) * 2006-08-08 2008-02-14 Leiden University Medical Center Methods and means for diagnosing and treatment of osteoarthritis
CN102154272B (en) * 2006-11-30 2014-03-12 爱科来株式会社 Primer set for amplification of obesity gene, reagent for amplification of obesity gene comprising primer set, and use of primer set
EP2322656A1 (en) * 2009-11-17 2011-05-18 Centre National de la Recherche Scientifique (C.N.R.S) Methods for diagnosing skin diseases
US20130137111A1 (en) * 2010-07-26 2013-05-30 Astellas Pharma Inc. Detection method of novel ret fusion

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750502A (en) * 1992-04-02 1998-05-12 The Trustees Of Columbia University In City Of New York Cloning, expression and uses of a secreted protein, F-spondin

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750502A (en) * 1992-04-02 1998-05-12 The Trustees Of Columbia University In City Of New York Cloning, expression and uses of a secreted protein, F-spondin

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
FAN J ET AL: "Genetic mapping: Finding and analyzing single-nucleotide polymorphisms with high-density DNA arrays", AMERICAN JOURNAL OF HUMAN GENETICS, UNIVERSITY OF CHICAGO PRESS, CHICAGO,, US, vol. 61, no. 4, SUPPL, 1 October 1997 (1997-10-01), pages 1601, XP002089397, ISSN: 0002-9297 *
POLYMEROPOULOS M H ET AL: "DINUCLEOTIDE REPEAT POLYMORPHISM AT THE HUMAN THROMBOSPONDIN GENE THBS1", NUCLEIC ACIDS RESEARCH, vol. 18, no. 24, 1990, pages 7467, XP002188932, ISSN: 0305-1048 *
WANG D G ET AL: "Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 280, 1998, pages 1077 - 1082, XP002089398, ISSN: 0036-8075 *

Also Published As

Publication number Publication date
WO2001018250A2 (en) 2001-03-15
EP1240354A2 (en) 2002-09-18
AU7119400A (en) 2001-04-10

Similar Documents

Publication Publication Date Title
WO2001077384A2 (en) Detection of single nucleotide polymorphisms (snp's) and cytosine-methylations
Mandal et al. Sequencing arrays for screening multiple genes associated with early-onset human retinal degenerations on a high-throughput platform
WO2001018250A3 (en) Single nucleotide polymorphisms in genes
KR101933601B1 (en) Specific primers for predicting hair loss and uses thereof
WO2001066800A8 (en) Human single nucleotide polymorphisms
Honeyman et al. Development of a snapback method of single-strand conformation polymorphism analysis for genotyping Golden Retrievers for the X-linked muscular dystrophy allele
Vaca et al. Deletion pattern of the STS gene in X-linked ichthyosis in a Mexican population
Lee et al. A non-radioactive method for simultaneous detection of single-strand conformation polymorphisms (SSCPs) and heteroduplexes
WO1999050454A3 (en) Coding sequence polymorphisms in vascular pathology genes
Patino-Garcıa et al. Screening of the human tumor necrosis factor-alpha (TNF-α) gene promoter polymorphisms by PCR–DGGE analysis
AU4766000A (en) Method for analysing a patient's genetic predisposition to at least a disease and amplification adapted to such a method
WO2003054167A3 (en) Identification of novel polymorphic sites in the human mglur8 gene and uses thereof
Chen et al. Detection of paternal uniparental disomy 9 in a neonate with prenatally detected mosaicism for a small supernumerary marker chromosome 9 and a supernumerary ring chromosome 9
Pamphlett et al. Copy number imbalances in blood and hair in monozygotic twins discordant for amyotrophic lateral sclerosis
Burchard et al. Development of a rapid clinical TPMT genotyping assay
Antonarakis et al. Molecular characterization of β‐globin gene mutations in patients with β‐thalassaemia intermedia in South China
WO2000058519A3 (en) Charaterization of single nucleotide polymorphisms in coding regions of human genes
WO2001042511A3 (en) Ibd-related polymorphisms
Petry et al. Identification of a novel mutation in the ARSB gene that is frequent among Brazilian MPSVI patients
EP1262565A3 (en) Genetic polymorphisms in the human neurokinin 1 receptor gene and their uses in diagnosis and treatment of diseases
DE69833104D1 (en) GLAUKOM DIAGNOSIS AND TREATMENT
WO2001038576A3 (en) Human single nucleotide polymorphisms
young Mun et al. SNPs detection by a single-strand specific nuclease on a PNA zip-code microarray
Collin et al. HumanDCTN1: Genomic Structure and Evaluation as a Candidate for Alström Syndrome
WO2002086147A3 (en) Single nucleotide polymorphisms diagnostic for schizophrenia

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP MX

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2000959964

Country of ref document: EP

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP MX

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

WWP Wipo information: published in national office

Ref document number: 2000959964

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2000959964

Country of ref document: EP